As of 2025-03-15, the Relative Valuation of TRYP Therapeutics Inc (TRYP.CN) is 0.06 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CAD, the upside of TRYP Therapeutics Inc based on Relative Valuation is -0.6%.
The range of the Relative Valuation is 0.06 - 0.06 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -1.2x - -1.2x | -1.2x |
| Fair Price | 0.06 - 0.06 | 0.06 |
| Upside | -0.6% - -0.6% | -0.6% |
| Date | P/E |